Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis
- PMID: 15934868
- DOI: 10.1517/14728214.10.2.299
Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis
Abstract
The development of specific targeted therapies, such as anti-TNF-alpha treatment, for chronic inflammatory disorders such as rheumatoid arthritis, has significantly improved treatment, although not all patients respond. Targeting cellular adhesion molecules and chemokines/chemokine receptors as regulators of the extravasation and migration of leukocytes may provide a novel approach for the treatment of these diseases. Moreover, the possibility of developing small-molecule antagonists offers an excellent method for the oral delivery of compounds with a short half-life.
Similar articles
-
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.Neth J Med. 2011 Sep;69(9):356-66. Neth J Med. 2011. PMID: 21978977 Review.
-
Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.Cell Mol Immunol. 2004 Oct;1(5):336-42. Cell Mol Immunol. 2004. PMID: 16285892 Review.
-
The role of chemokines in rheumatoid arthritis and osteoarthritis.Scand J Rheumatol. 2005 Nov-Dec;34(6):415-25. doi: 10.1080/03009740500439159. Scand J Rheumatol. 2005. PMID: 16393761 Review.
-
Therapeutic inhibition of leukocyte recruitment in inflammatory diseases.Curr Opin Pharmacol. 2004 Aug;4(4):423-8. doi: 10.1016/j.coph.2004.03.013. Curr Opin Pharmacol. 2004. PMID: 15251139 Review.
-
Chemokine inhibition in inflammatory arthritis.Best Pract Res Clin Rheumatol. 2006 Oct;20(5):929-39. doi: 10.1016/j.berh.2006.06.001. Best Pract Res Clin Rheumatol. 2006. PMID: 16980215 Review.
Cited by
-
Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.Int J Nanomedicine. 2021 Dec 31;16:8485-8507. doi: 10.2147/IJN.S334298. eCollection 2021. Int J Nanomedicine. 2021. PMID: 35002240 Free PMC article. Review.
-
Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review.ACS Pharmacol Transl Sci. 2024 May 28;7(6):1664-1693. doi: 10.1021/acsptsci.4c00067. eCollection 2024 Jun 14. ACS Pharmacol Transl Sci. 2024. PMID: 38898941 Review.
-
Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines.Bioorg Med Chem. 2012 Sep 1;20(17):5229-34. doi: 10.1016/j.bmc.2012.06.050. Epub 2012 Jul 7. Bioorg Med Chem. 2012. PMID: 22854193 Free PMC article.
-
Modified huo-luo-xiao-ling dan suppresses adjuvant arthritis by inhibiting chemokines and matrix-degrading enzymes.Evid Based Complement Alternat Med. 2012;2012:589256. doi: 10.1155/2012/589256. Epub 2012 Mar 7. Evid Based Complement Alternat Med. 2012. PMID: 22474510 Free PMC article.
-
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.Nat Rev Rheumatol. 2016 Jan;12(1):5-13. doi: 10.1038/nrrheum.2015.157. Epub 2015 Nov 26. Nat Rev Rheumatol. 2016. PMID: 26607389 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical